Pages that link to "Q36383057"

The following pages link to Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness (Q36383057):

Displaying 37 items.

• Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer (Q26739708) (← links)
• Role of microRNAs in chemoresistance (Q26770485) (← links)
• Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism (Q26774456) (← links)
• Notch signaling in prostate cancer: refining a therapeutic opportunity (Q26777624) (← links)
• Insights into Chemoresistance of Prostate Cancer (Q26795589) (← links)
• Uncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancer (Q27014171) (← links)
• MicroRNAs targeting prostate cancer stem cells (Q28081039) (← links)
• A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells (Q28573536) (← links)
• Amygdala-dependent fear memory consolidation via miR-34a and Notch signaling (Q30587469) (← links)
• Network analysis of ChIP-Seq data reveals key genes in prostate cancer (Q30847259) (← links)
• MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer (Q33785102) (← links)
• A potential regulatory loop between Lin28B:miR‑212 in androgen-independent prostate cancer. (Q34432845) (← links)
• The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells (Q35000256) (← links)
• The impact of microRNA expression on cellular proliferation (Q36367578) (← links)
• Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience (Q36844904) (← links)
• Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines (Q37189513) (← links)
• The role of microRNAs in the regulation of cancer stem cells (Q37428403) (← links)
• miR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinoma (Q37596868) (← links)
• MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway (Q37706591) (← links)
• MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling (Q37716420) (← links)
• Obesity, Diabetes and Cancer: A Mechanistic Perspective (Q37730336) (← links)
• miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells (Q38096240) (← links)
• MicroRNAs and drug resistance in prostate cancers (Q38205266) (← links)
• Mir-34: a new weapon against cancer? (Q38253374) (← links)
• The Secret Role of microRNAs in Cancer Stem Cell Development and Potential Therapy: A Notch-Pathway Approach (Q38365386) (← links)
• Gene interference strategies as a new tool for the treatment of prostate cancer (Q38518046) (← links)
• KRT6B, a key mediator of notch signaling in honokiol-induced human hepatoma cell apoptosis (Q38814986) (← links)
• miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells (Q38987842) (← links)
• Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer (Q39449489) (← links)
• Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms (Q39907903) (← links)
• Notch1/3 and p53/p21 are a potential therapeutic target for APS-induced apoptosis in non-small cell lung carcinoma cell lines (Q41906886) (← links)
• Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer (Q47098499) (← links)
• Molecular and cellular mechanisms of castration resistant prostate cancer. (Q52608488) (← links)
• LncRNA FEZF1-AS1 Sponges miR-34a to Upregulate Notch-1 in Glioblastoma (Q90636837) (← links)
• Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer (Q91676732) (← links)
• Relations between approved platinum drugs and non-coding RNAs in mesothelioma (Q91949964) (← links)
• Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma (Q91949972) (← links)